MOREADITH RANDALL (Chief Scientific Officer) sold 3.56K shares of SERINA THERAPEUTICS, INC. on the open market
Open‑market sale worth $11.5K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/12/2025ACC: 0001301120-25-000030
Officer· Chief Scientific Officer
Since Feb 2026
-3.56K
Net shares
Net seller
$11.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.56K acquired · 7.11K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.56K
Price / share
$0.06
Trade value
$213.30
% of position
New position
12/11/2025
0.00→3.56K
Common Stock
Direct
Shares
−3.56K
Price / share
$3.24
Trade value
$11.52K
% of position
New position
12/11/2025
3.56K→0.00
Total
Net shares
+0.00
Net value
-$11.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/11/2025 | M · Option Exercise | +3.56K | $0.06 | $213.30 | New position | 0.00 | 3.56K |
| Common Stock Direct | 12/11/2025 | S · Sale | −3.56K | $3.24 | $11.52K | New position | 3.56K | 0.00 |
| Total | +0.00 | -$11.31K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
3.56K shares
Shares
−3.56K
Strike price
0.06
Held after
366.89K
Exercisable
—
12/11/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock3.56K shares | 12/11/2025 | M · Option Exercise | −3.56K | 0.06 | — | 366.89K |